Movement Alert｜HCA Healthcare Rises 3.04% in Regular Trading, CRISPR Gene Therapy Pediatric Study Published in NEJM Boosts Sentiment

Market Focus07-02 21:57

On July 2, HCA Healthcare rose 3.04% in regular trading, trading at $413.4/share, with turnover of $119 million. The move was driven by the publication of a landmark CRISPR gene-editing therapy study in the New England Journal of Medicine, in which HCA participated.

The study evaluated CRISPR-based gene therapy in children aged 5 to 11 with severe sickle cell disease and transfusion-dependent beta-thalassemia. Results showed all 8 beta-thalassemia patients achieved at least 12 months of transfusion independence, and all 8 sickle cell disease patients experienced no severe vaso-occlusive crises over at least 12 months. HCA is expanding access to this therapy through its Sarah Cannon Transplant and Cellular Therapy Network.

Within the Health Care Facilities sector, the broader group showed strength. Among individual stocks, Tenet Healthcare up 5.81%, Universal Health up 4.26%, Encompass Health Corporation up 3.07%, Acadia Healthcare up 2.75%, Nutex Health Inc up 1.2%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104824139?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 21:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104824139","market":"us","top_or_hot":-1,"title":"Movement Alert｜HCA Healthcare Rises 3.04% in Regular Trading, CRISPR Gene Therapy Pediatric Study Published in NEJM Boosts Sentiment","media":"Market Focus","content":"<p><p>On July 2, HCA Healthcare rose 3.04% in regular trading, trading at $413.4/share, with turnover of $119 million. The move was driven by the publication of a landmark CRISPR gene-editing therapy study in the New England Journal of Medicine, in which HCA participated.</p><p>The study evaluated CRISPR-based gene therapy in children aged 5 to 11 with severe sickle cell disease and transfusion-dependent beta-thalassemia. Results showed all 8 beta-thalassemia patients achieved at least 12 months of transfusion independence, and all 8 sickle cell disease patients experienced no severe vaso-occlusive crises over at least 12 months. HCA is expanding access to this therapy through its Sarah Cannon Transplant and Cellular Therapy Network.</p><p>Within the Health Care Facilities sector, the broader group showed strength. Among individual stocks, Tenet Healthcare up 5.81%, Universal Health up 4.26%, Encompass Health Corporation up 3.07%, Acadia Healthcare up 2.75%, Nutex Health Inc up 1.2%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜HCA Healthcare Rises 3.04% in Regular Trading, CRISPR Gene Therapy Pediatric Study Published in NEJM Boosts Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜HCA Healthcare Rises 3.04% in Regular Trading, CRISPR Gene Therapy Pediatric Study Published in NEJM Boosts Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-02 21:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 2, HCA Healthcare rose 3.04% in regular trading, trading at $413.4/share, with turnover of $119 million. The move was driven by the publication of a landmark CRISPR gene-editing therapy study in the New England Journal of Medicine, in which HCA participated.</p><p>The study evaluated CRISPR-based gene therapy in children aged 5 to 11 with severe sickle cell disease and transfusion-dependent beta-thalassemia. Results showed all 8 beta-thalassemia patients achieved at least 12 months of transfusion independence, and all 8 sickle cell disease patients experienced no severe vaso-occlusive crises over at least 12 months. HCA is expanding access to this therapy through its Sarah Cannon Transplant and Cellular Therapy Network.</p><p>Within the Health Care Facilities sector, the broader group showed strength. Among individual stocks, Tenet Healthcare up 5.81%, Universal Health up 4.26%, Encompass Health Corporation up 3.07%, Acadia Healthcare up 2.75%, Nutex Health Inc up 1.2%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCA","symbol_name":"HCA控股","start_time":0,"source_url":"","article_id":"1104824139","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104824139","pubTimestamp":1783000671,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 2, HCA Healthcare rose 3.04% in regular trading, trading at $413.4/share, with turnover of $119 million. The move was driven by the publication of a landmark CRISPR gene-editing therapy study...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCA":"HCA控股"},"translate_title":"动向预警|HCA Healthcare常规交易涨3.04%CRISPR基因疗法儿科研究发表于NEJM提振人气","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCA":1},"content_text":"On July 2, HCA Healthcare rose 3.04% in regular trading, trading at $413.4/share, with turnover of $119 million. The move was driven by the publication of a landmark CRISPR gene-editing therapy study in the New England Journal of Medicine, in which HCA participated.The study evaluated CRISPR-based gene therapy in children aged 5 to 11 with severe sickle cell disease and transfusion-dependent beta-thalassemia. Results showed all 8 beta-thalassemia patients achieved at least 12 months of transfusion independence, and all 8 sickle cell disease patients experienced no severe vaso-occlusive crises over at least 12 months. HCA is expanding access to this therapy through its Sarah Cannon Transplant and Cellular Therapy Network.Within the Health Care Facilities sector, the broader group showed strength. Among individual stocks, Tenet Healthcare up 5.81%, Universal Health up 4.26%, Encompass Health Corporation up 3.07%, Acadia Healthcare up 2.75%, Nutex Health Inc up 1.2%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104824139","isCrawlerRequest":true}